Skip to main content

Share story

Policy

Anthropic and Pentagon argue over military use of Claude models

Anthropic and Pentagon argue over military use of Claude models Image: Primary
The Pentagon is pushing AI companies including Anthropic to allow the U.S. military to use their technology for all lawful purposes. Anthropic has pushed back more than the others, according to a report in Axios. The government has made the same request to OpenAI, Google, and xAI. An anonymous Trump administration official told Axios that one of those companies has agreed while the other two have shown some flexibility. The Pentagon is reportedly threatening to end its 200 million dollar contract with Anthropic as a result of the resistance. In January the Wall Street Journal reported significant disagreement between Anthropic and Defense Department officials over how its Claude models could be used. The publication later said that Claude was used in the U.S. military operation to capture then Venezuelan president Nicolas Maduro. A company spokesperson told Axios that Anthropic has not discussed the use of Claude for specific operations with the Department of War. The company is instead focused on usage policy questions including its hard limits around fully autonomous weapons and mass domestic surveillance. Anthropic did not immediately respond to a request for comment from TechCrunch.
Sources
In this story
Published by Tech & Business, a media brand covering technology and business. This story was sourced from TechCrunch and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Capital
Capital

Nominal raises $240 million at a $3 billion valuation

Nominal has raised $240 million at a $3 billion valuation, triple its valuation in a funding round earlier this year, Bloomberg reports. The startup builds software to make manufacturing more efficient.

Capital Products
Capital Products

Onodrim raises $300M to acquire European defence and industrial suppliers

Amsterdam-based Onodrim Industries has raised $300M in a round led by Lux Capital, valuing the defence group at $1.3bn, the company said Monday. Other investors include General Catalyst, Lakestar and Altimeter. The financing follows its €40M seed round in February.

Capital
Capital

SRTD Biotech raises €31.5 million for targeted RNA therapies

SRTD Biotech has completed an oversubscribed €31.5 million seed financing to develop RNA therapies designed to act selectively inside diseased cells. Mérieux Equity Partners led the round, with NRW.BANK and Boehringer Ingelheim Venture Fund joining as co-leads.